# Superselective Adrenal Arterial Embolization for Bilateral Idiopathic Hyperaldosteronism: A Prospective Cohort Study

> **NCT05186675** · NA · UNKNOWN · sponsor: **Second Affiliated Hospital of Nanchang University** · enrollment: 50 (estimated)

## Conditions studied

- Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral)

## Interventions

- **PROCEDURE:** superselective adrenal arterial embolization

## Key facts

- **NCT ID:** NCT05186675
- **Lead sponsor:** Second Affiliated Hospital of Nanchang University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-01
- **Primary completion:** 2022-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2022-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05186675

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05186675, "Superselective Adrenal Arterial Embolization for Bilateral Idiopathic Hyperaldosteronism: A Prospective Cohort Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05186675. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*